Office of the Secretary; Notice of Meeting, 87883 [2024-25650]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices
designated, the name of the service area,
population group, or facility involved is
listed under the county name. A county
that has a whole county geographic or
population group HPSA is indicated by
the phrase ‘‘County’’ following the
county name.
ddrumheller on DSK120RN23PROD with NOTICES1
Development of the Designation and
Withdrawal Lists
HRSA continuously receives requests
for designation or withdrawal of a
particular geographic area, population
group, or facility as a HPSA. Under a
Cooperative Agreement between HRSA
and the 54 state and territorial primary
care offices (PCOs), PCOs conduct needs
assessments and submit applications to
HRSA to designate HPSAs. HRSA refers
requests that come from other sources to
PCOs for review. In addition, interested
parties, including governors, state
primary care associations, and state
professional associations, are notified of
requests so that they may submit their
comments and recommendations.
HRSA reviews each recommendation
for possible addition, continuation,
revision, or withdrawal. Following
review, HRSA notifies the appropriate
agency, individuals, and interested
organizations of each designation of a
HPSA, rejection of recommendation for
HPSA designation, revision of a HPSA
designation, and/or advance notice of
pending withdrawals from the HPSA
list. Designations (or revisions of
designations) are effective as of the date
on the notification from HRSA and are
updated daily on the HRSA Data
Warehouse website. The effective date
of a withdrawal will be the next
publication of a notice regarding the list
of designated HPSAs in the Federal
Register.
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Date: December 4, 2024.
Time: 10:15 a.m. to 4:00 p.m. Eastern Time
(ET).
Agenda: Interagency Pain Research
Coordinating Committee member updates
and other committee business, including
Federal Pain Research Strategy research
progress, communication and dissemination
strategies, and workgroup updates.
Webcast Live: https://videocast.nih.gov/.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Leah Pogorzala, Ph.D.,
Policy Analyst, Office of Pain Policy and
Planning, Office of the Director, National
Institute of Neurological Disorders and
Stroke, NIH, Bethesda, MD 20892, Phone:
(301) 496–4228, Email: leah.pogorzala@
nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Written comments should be submitted
to the contact person by 5:00 p.m. ET on
November 27, 2024.
Information is also available on the
IPRCC website https://iprcc.nih.gov,
where an agenda and any additional
information for the meeting will be
posted when available.
Diana Espinosa,
Principal Deputy Administrator.
Dated: October 30, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25624 Filed 11–4–24; 8:45 am]
[FR Doc. 2024–25650 Filed 11–4–24; 8:45 am]
BILLING CODE 4165–15–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following Meetings.
The Meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:07 Nov 04, 2024
Jkt 265001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
87883
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Developmental Biology.
Date: December 2, 2024.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anne Marie Strohecker,
Ph.D., Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 867–5309,
stroheckeram@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Health Services and Systems B.
Date: December 3–4, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tara Roshell Earl, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C,
Bethesda, MD 20892, (301) 402–6857, earltr@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial Diagnostics, Detection
and Decontamination.
Date: December 3–4, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Special topics in Mechanistic and
Clinical Neuroscience.
Date: December 3, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, (301) 435–
1259, nadis@csr.nih.gov.
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 89, Number 214 (Tuesday, November 5, 2024)]
[Notices]
[Page 87883]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25650]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain Research Coordinating
Committee.
Date: December 4, 2024.
Time: 10:15 a.m. to 4:00 p.m. Eastern Time (ET).
Agenda: Interagency Pain Research Coordinating Committee member
updates and other committee business, including Federal Pain
Research Strategy research progress, communication and dissemination
strategies, and workgroup updates.
Webcast Live: https://videocast.nih.gov/.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Leah Pogorzala, Ph.D., Policy Analyst, Office of
Pain Policy and Planning, Office of the Director, National Institute
of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892,
Phone: (301) 496-4228, Email: [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Written comments should be submitted to the
contact person by 5:00 p.m. ET on November 27, 2024.
Information is also available on the IPRCC website https://iprcc.nih.gov, where an agenda and any additional information for the
meeting will be posted when available.
Dated: October 30, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-25650 Filed 11-4-24; 8:45 am]
BILLING CODE 4140-01-P
